108 related articles for article (PubMed ID: 7124858)
1. Circadian pattern of prolactin secretion in postmenopausal women receiving estrogen with or without progestin.
Chang RJ; Davidson BJ; Carlson HE; Judd HL
Am J Obstet Gynecol; 1982 Oct; 144(4):402-7. PubMed ID: 7124858
[TBL] [Abstract][Full Text] [Related]
2. The influence of exogenous estrogen on the circadian periodicity of circulating prolactin in women.
Vekemans M; Robyn C
J Clin Endocrinol Metab; 1975 May; 40(5):886-9. PubMed ID: 1127094
[TBL] [Abstract][Full Text] [Related]
3. The effect of contraceptive steroids on hypothalamic-pituitary function.
Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
[TBL] [Abstract][Full Text] [Related]
4. Increase of serum prolactin during combined high-dose estrogen and progestin treatment in girls with constitutional tall stature.
Houdijk EC; Delemarre-van de Waal HA
Acta Paediatr; 2000 Dec; 89(12):1504-5. PubMed ID: 11195249
[No Abstract] [Full Text] [Related]
5. The effect of estrogen-progestin treatment on opioid control of gonadotropin and prolactin secretion in postmenopausal women.
Dawood MY; Khan-Dawood FS; Ramos J
Am J Obstet Gynecol; 1986 Dec; 155(6):1246-51. PubMed ID: 3024488
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man.
Wiedemann E; Schwartz E; Frantz AG
J Clin Endocrinol Metab; 1976 May; 42(5):942-52. PubMed ID: 178687
[TBL] [Abstract][Full Text] [Related]
8. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
Weissberger AJ; Ho KK; Lazarus L
J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
[TBL] [Abstract][Full Text] [Related]
10. Double-blind crossover clinical pharmacology study comparing moxestrol (R 2858) and ethinyl estradiol in postmenopausal women.
Robyn C; Vekemans M; Rozencweig M; Chigot D; Raynaud JP
J Clin Pharmacol; 1978 Jan; 18(1):29-34. PubMed ID: 338643
[TBL] [Abstract][Full Text] [Related]
11. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
12. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
Bellantoni MF; Harman SM; Cho DE; Blackman MR
J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
[TBL] [Abstract][Full Text] [Related]
13. Mutual modification of glucose-stimulated serum insulin responses in female rhesus monkeys by ethinyl estradiol and nortestosterone derivatives.
Beck P; Venable RL; Hoff DL
J Clin Endocrinol Metab; 1975 Jul; 41(1):44-53. PubMed ID: 50326
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
Spona J; Huber J; Schmidt JB
Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
[TBL] [Abstract][Full Text] [Related]
15. Regulation of lactogenic hormone binding in rat liver by steroid hormones.
Sherman BM; Stagner JI; Zamudio R
Endocrinology; 1977 Jan; 100(1):101-7. PubMed ID: 187403
[TBL] [Abstract][Full Text] [Related]
16. The effect of ethynyloestradiol and medroxyprogesterone acetate on the in vivo uptake and metabolism of 3H-oestradiol by breast tumour tissue in postmenopausal women.
Reed MJ; Beranek PA; Bonney RC; Ghilchik MW; James VH
Anticancer Res; 1987; 7(6):1265-9. PubMed ID: 2831795
[TBL] [Abstract][Full Text] [Related]
17. Estrogen feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
Nishi T; Nakano R; Yagi S
Horm Res; 1989; 32(5-6):193-7. PubMed ID: 2517493
[TBL] [Abstract][Full Text] [Related]
18. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
Hirvonen E; Mälkönen M; Manninen V
N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
[TBL] [Abstract][Full Text] [Related]
19. A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal women.
Urban RJ; Veldhuis JD
Am J Obstet Gynecol; 1991 Jan; 164(1 Pt 1):147-52. PubMed ID: 1986602
[TBL] [Abstract][Full Text] [Related]
20. Progestins increase endogenous opioid peptide activity in postmenopausal women.
Casper RF; Alapin-Rubillovitz S
J Clin Endocrinol Metab; 1985 Jan; 60(1):34-6. PubMed ID: 3155455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
